Investing Profile

Markus Goebel

Advisor
Biotech & Medtech consulting
Switzerland
Photo of Markus Goebel, Advisor
Your Intro Paths to Markus Goebel

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →

Find Markus Goebel on

cb
Current Investing Position
Advisor
Investments On Record
4

Markus Goebel is on these Sector & Stage Rankings

Markus Goebel's Investments On Record (2)

CompanyStageDateRound SizeTotal Raised
Merganser Biotech
Series AFeb 2015$28M
$28M
Co-investors: James N. Topper (Frazier Healthcare Partners)
Sorbent Therapeutics
Series DMay 2014$7M
Series CAug 2012$18M
Series BJun 2011$36M
$86M
Co-investors: Scott Minick (ARCH Venture Partners)

Markus Goebel's Experience

Expert Innosuisse2022 - Present
CEO M&G Advisors GmbH2019 - Present
Director HAYA Therapeutics SA2020 - 2020
Managing Director Novartis Venture Fund2004 - 2019
Head Pharma Corporate M&A Novartis2002 - 2004
Head Nervous System BD&L Pharma Novartis2000 - 2002
Several Marketing & Strategy positions incl. an alliance with Amgen Roche1992 - 1999
Medical Manager Oncology & Medical Science FARMITALIA CARLO ERBA LIMITED1990 - 1992

Markus Goebel's Education

Henley Business School Master of Business Administration - MBA
Ludwig-Maximilians Universität München Doctor of Medicine - MD
University of Hamburg PhD ADPRibosylation
Henley Management College MBA
Ludwig-Maximilians Universität München MD